Table 1 (abstract P2043). Diagnostic power, sensitivity, and specificity of NBO diagnostic sets
From: 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
The set of criteria | The maximal possible number of patients with TBO, who may be false-diagnosed as NBO, n (%) | RR (95%CI) | Se | Sp |
|---|---|---|---|---|
Jansson, 2009 | 29/33 (87.9) | 0.14 (0.06-0.35) | 0.12 | 0.12 |
Jansson 2011 | 7/33 (21.2) | 3.7 (1.9-7.3) | 0.79 | 0.79 |
Roderick, 2016 | 5/33 (15.2) | 5.6 (2.5-12.7) | 0.85 | 0.85 |
Our criteria | For NBO | Â | Â | Â |
 Major criteria | 0 (100.0) | na | 1.0 | 1.0 |
 ≥2 minor criteria | 32/91 (35.2) | 1.84 (1.3-2.5) | 0.65 | 0.65 |
 ≥3 minor criteria | 11/91 (12.1) | 7.3 (4.2-12.7) | 0.88 | 0.88 |
 ≥4 minor criteria | 0/91 (0.0) | na | 1.0 | 1.0 |